Defects in NK and NKT cell activities have been implicated in the etiology of type 1 (autoimmune) diabetes in NOD mice on the basis of experiments performed using surrogate phenotypes for the identification of these lymphocyte subsets. Here, we have generated a congenic line of NOD mice (NOD.b-Nkrp1 b ) which express the allelic NK1.1 marker, enabling the direct study of NK and NKT cells in NOD mice. Major deficiencies in both populations were identified when NOD.b-Nkrp1 b mice were compared with C57BL/6 and BALB.B6-Cmv1 r mice by flow cytometry. The decrease in numbers of peripheral NK cells was associated with an increase in their numbers in the bone marrow, suggesting that a defect in NK cell export may be involved. In contrast, the most severe deficiency of NKT cells found was in the thymus, indicating that defects in thymic production were probably responsible.
Introduction
NOD mice are widely used as a spontaneous model of type 1 New evidence has recently thrown light on the role of the innate immune system in regulation of adaptive responses. (autoimmune) diabetes mellitus (1) . In addition to diabetes, NOD mice develop signs of systemic autoimmunity such as
Of particular interest are the roles of two families of immunoregulatory lymphocytes, the NK and NKT cells. NK cells are antinuclear autoantibodies (ANA) and hemolytic anemia (HA) in old age (2) . Furthermore, exposure to killed mycobacteria large granular lymphocytes which secrete several proinflammatory cytokines, including IFN-γ, and mediate cytotoxicity results in the precipitation of an autoimmune disease which resembles systemic lupus erythematosus (SLE) in humans, against a broad range of targets, such as MHC class Ideficient virally infected cells and tumor cells (5) . NKT cells and is characterized by enhancement of ANA, precipitation of HA and the induction of immune complex glomerulonephritis are a population of lymphocytes which co-express the αβTCR, as well as receptors characteristic of NK cells and rapidly (3, 4) . This multiplicity of autoimmune phenomena in NOD mice suggests the presence of a fundamental defect in produce large amounts of cytokine, including IL-4 (6,7). The TCR repertoire expressed by NKT cells is unusually immune control affecting their ability to induce and maintain immunological tolerance (1) .
restricted-to V α 14-J α 281 and V β 8, V β 7 or V β 2 in the mouse (8,9) and V α 24, J α Q and V β 11 in humans (10). NKT cells are here therefore represent the first detailed study of NK and NKT cell numbers and function in NOD mice. activated on recognition of the class I-like, β 2 microglobulin (β 2 m)-dependent leukocyte surface antigen, CD1d (11, 6, 12 ), which appears to act as a restriction element for the presentaMethods tion of glycolipids such as glycosylphosphatidylinositol (GPI) (13) and phosphatidylinositolmannosides (PIM) (14) .
Mice Kataoka et al. (15) reported that splenocytes from NOD mice NOD/Lt, BALB/c, BALB.B6-Cmv1 r and C57BL/6J mice were exhibit a defect in NK cell cytotoxic function as evidenced by obtained from the Animal Resource Centre (Canning Vale, decreased killing of YAC-1 target cells in vitro. The presence WA, Australia). BALB.B6-Cmv1 r mice are a BALB/c-based of this defect has been confirmed with the same assay by congenic strain which carries the NK-related complex from others (16) . Although FACS analysis of splenocytes from NOD C57BL/6 mice (25) . The breeding of specific crosses was mice revealed a complete absence of NK1.1 ϩ lymphocytes performed within the animal facility at the Centenary Institute (16) , this was subsequently demonstrated to be caused by (Sydney, Australia). Mice were housed in clean conditions the absence of the NK1.1 allelic marker in this strain (17) (18) (19) .
and sentinel mice were tested by serology at 4-monthly The defect in NK activity in NOD mice cannot be attributed intervals for the following pathogens: mouse hepatitis virus, to the lack of the NK1.1 allele, because BALB/c mice, which rotavirus, ectomelia, mouse cytomegalovirus, polyoma virus, also lack the NK1.1 allele, have functional NK cells (20 5 αβ ϩ double-negative thymic NKT male mouse and the progeny were serially back-crossed to cells and that this protection is mediated by an IL-4-dependent NOD/Lt mice to generation N10. At each generation after F 1 , mechanism (22) . Gombert et al. (17) also studied NKT cell breeders were selected by flow cytometry for expression of function in vivo in NOD mice by measuring the production of the B6-associated NK1.1 allelic marker on peripheral blood IL-4 following injection of anti-CD3 mAb, as described by leukocytes. At N10, heterozygous mice were intercrossed Yoshimoto and Paul (23) . They found that at the age of [3] [4] [5] and their progeny analyzed by flow cytometry and PCR weeks, NOD mice produced no more IL-4 in response to this of D6Mit135 (Research Genetics, Huntsville, AL), a simple challenge than did NKT cell-deficient NOD.β 2 m -/-mutant sequence repeat (SSR) tightly linked to the NK-related commice. Furthermore, a similar deficit was found following stimuplex on chromosome 6. Homozygous mice carrying the B6 lation of HSA -CD8 -thymocytes in vitro, suggesting the allele at this locus were used to found the new congenic line, possibility that NKT cells from NOD mice may be deficient in while heterozygous mice were maintained for 8 months to IL-4 production on a per cell basis-a finding supported assess the incidence of spontaneous diabetes. by us using intracellular cytokine staining of αβTCR ϩ DN thymocytes (22) .
Flow cytometric analysis Lehuen et al. (24) subsequently confirmed the protective Antibodies. Anti-Pan-NK (clone DX5) conjugated to phycoerrole of NKT cells in NOD mice by increasing their numbers ythrin (PE), CD161/NK1.1 (clone PK136) conjugated to biotin through the introduction of a transgene encoding the NKT or PE, anti-CD4 (clone RM4-5) conjugated to biotin or PE, cell-associated TCR V α 14-J α 281 chain. Mild protection from anti-CD8α (clone 53-6.7) conjugated to PE, biotin or allophycospontaneous diabetes and a more robust protection from cyanin (APC), anti-TCRαβ (clone H57-597) conjugated to cyclophosphamide-precipitated diabetes was seen in the FITC or APC, anti-IL-4 (clone 11B11) conjugated to PE and transgenic lines with the most NKT cells. In order to determine anti-IFN-γ (clone XMG1.2) conjugated to FITC were all the numbers of NKT cells in these transgenic lines, the obtained from PharMingen (San Diego, CA). Purified rabbit authors crossed them to NOD.b-Nkrp1 b mice (referred to as anti-asialo-GM 1 was obtained from Wako Pure Chemicals NOD.NK1.1 congenic mice in the manuscript cited), a novel Industries (Richmond, VA), streptavidin-Texas Red was line of NOD mice congenic for the NK-related complex on obtained from Molecular Probes (Eugene, OR) and goat chromosome 6. Unfortunately, the manuscript contains very anti-rabbit-FITC was obtained from Southern Biotechnology little information on the characterization of this line. As NOD.b-(Birmingham AL). Nkrp1 b mice offer enormous advantages in the study of NK and NKT cells in NOD mice, we have independently generated CD1-α-GalCer tetramer. CD1-α-GalCer tetramer was kindly another line of these mice by the traditional method of provided by Dr Mitchell Kronenberg and was prepared as previously described (26) . backcrossing and phenotypic selection. The data presented and washed. Control samples were prepared from cells which were cultured without anti-CD3 stimulation or the addition of Brefeldin A. Samples were surface stained as described above, fixed in 4% formaldehyde in PBS and then stained intracellularly with anti-IL-4 and/or anti-IFN-γ or the appropriate were analyzed on a FACStar Plus flow cytometer.
In vitro NK cell cytotoxicity assay
NK cell cytotoxicity of freshly isolated splenocytes from Preparation of lymphocytes. Single-cell suspensions of C57BL/6, NOD/Lt and NOD.b-Nkrp1 b mice was examined in lymphocytes from blood, bone marrow, lymph nodes (pooled a 4-h 51 Cr-release assay. Target cells were generated by inguinal, cervical and axillary), spleen and thymus were stimulating splenocytes from C57BL/6, C57BL/6.β 2 m -/-, NOD/ prepared by standard techniques (19). Livers were pressed Lt or NOD.β 2 m -/-mice with phorbol myristate acetate (1 ng/ through a 200 gauge stainless steel mesh screen and washed ml; Sigma) and ionomycin (1 µg/ml; Sigma) for 24 h. Target at least twice. Lymphocytes were then separated out using cells (2.0ϫ10 4 /well) were mixed with freshly isolated effector a 37.5% Percoll (Amersham Pharmacia Biotech, Uppsala, splenocytes in E:T ratios of 100, 50, 20 10, 5 and 1:1. Maximal Sweden) gradient. The cells were then treated with red blood lysis was determined by detergent-mediated membrane discell lysing buffer (Sigma, St Louis, MO). ruption and percent lysis was calculated as (specific lysisspontaneous lysis)/(maximal lysis -spontaneous lysis)ϫ100. Cell surface staining. Staining was carried out in 96-well
The spontaneous release of 51 Cr was always Ͻ15% of maximal U-bottom plates. Cells were initially incubated with anti-CD16/ release and two tests were performed using triplicate samples. CD32 (anti-FcγRIII/II; clone 2.4G2) to prevent non-specific LU 20 values were calculated from the intersect of the 20:1 binding of subsequent mAb and then incubated with the ratio with a line of best fit on a plot of lysis versus E:T ratio appropriate mixture of mAb for 30 min at 4°C. Secondary and were expressed as the number of units per 10 7 effector staining reagents were then added when necessary and splenocytes or 10 6 effector NK cells. In order to confirm that incubated as before. The cells were analyzed on a FACScan lysis observed was due to cells expressing NK1.1, one group or FACStar Plus flow cytometer (Becton Dickinson, San of mice was treated in vivo with PK136 (anti-NK1.1) 7 days Jose, CA).
prior to the splenocytes being harvested.
Intracellular cytokine staining. Twenty-four-well flat-bottom
In vivo NK cell cytotoxicity assay plates were coated with anti-CD3 (KT3, 10 µg/ml in pH 9.1 carbonate buffer). The cells were then added at 2ϫ10 6 cells/ NK cell activity was studied in vivo using a model adapted from that of Bix et al. (27) . NOD/Lt and NOD.β 2 m -/-bone well in 1.5 ml T cell medium [RPMI 1640 (Gibco/BRL, Grand Island, NY) with 10% fetal calf serum (FCS), 1% L-glutamine marrow cells were fluorescently labeled before being injected i.v. into irradiated C57BL/6, NOD/Lt and NOD.b-Nkrp1 b mice. (Sigma) and 5ϫ10 -5 M 2-mercaptoethanol (Sigma)] and the plates were incubated at 37°C with 5% CO 2 for 1-2 h; Brefeldin Bone marrow was obtained from the femurs and tibias of donor mice, and treated with anti-CD4 (RL172.4), anti-CD8 A (5 µg/ml; Sigma) was subsequently added and the plates incubated for a further 4 h before the cells were harvested (3.155) and rabbit complement to deplete T cells. Viable cells were recovered over a Histopaque-1083 (Sigma) gradient A flow cytometric comparison was then performed on lymphocytes from thymus, spleen, peripheral lymph nodes, and then directly labeled at 5ϫ10 6 cells/ml with 2 µM carboxyfluorescein diacetate succinimidyl esters [CFSE (28) ;
liver, blood and bone marrow from 8-week-old female NOD.bNkrp1 b (n ϭ 5), C57BL/6 (n ϭ 5) and BALB.B6-Cmv1 r (n ϭ Molecular Probes, Eugene, OR] in PBS at room temperature for 10 min. Labeled cells were washed and injected i.v. into 5) mice. With the exception of the liver and blood, total numbers of lymphocytes obtained from each organ did not the tail veins of lethally irradiated (940 rad) recipient mice (5ϫ10 6 /mouse). After a period of 2-5 days, the recipient mice differ significantly between strains. More lymphocytes were obtained from the livers of BALB/c and B6 mice and from the were killed, and the femurs, tibias and spleens taken for quantification of donor cells by flow cytometry. By prior blood of B6 mice than from those of NOD.b-Nkrp1 mice (Table 1) . experimentation, it was determined that a 3-day period of engraftment ensured maximum spread of CFSE brightness
The peripheral blood, spleen and lymph nodes of NOD.bNkrp1 mice were significantly deficient in NK (NK1.1 ϩ αβTCR -) amongst dividing cells without the labeled population merging into the background of unstained cells. cells (Table 1 ). The numbers of NK cells in the livers of NOD.bNkrp1 mice were also reduced, although the proportion of Statistical analyses hepatic leukocytes that were NK cells in the NOD.b-Nkrp1 mice differed significantly from that of BALB but not that of Qualitative differences between samples were examined B6 mice. In stark contrast to the deficiency of NK cells in the using the 4-fold table (χ 2 ) test unless the expected value in peripheral organs, NOD.b-Nkrp1 mice had twice as many NK any cell was ഛ5, in which case the Fisher's exact test cells in the bone marrow as B6 mice and 5 times that of was used. Quantitative differences between samples were BALB mice (Table 1) . These findings may reflect either a compared using the Mann-Whitney U (rank-sum)-test or block in NK cell export or a compensatory increase in NK ANOVA as appropriate. A goodness of fit (χ 2 ) test was cell production by the bone marrow. used to compare proportions of affected animals with those predicted by modeling.
Flow cytometric comparison of NKT cells in NOD.b-Nkrp1 b , C57BL/6 and BALB.B6-Cmv1 r congenic mice
The thymuses and lymph nodes of NOD.b-Nkrp1 mice were Results profoundly deficient in NK1.1 ϩ αβTCR ϩ NKT cells (Table 1 ).
The numbers of NKT cells in the other organs was similar Incidence of diabetes in NOD.b-Nkrp1 b congenic mice
between the NOD.b-Nkrp1 and BALB mice, although the Genotypic analysis of N10 and N10F 1 (first intercross of N10)
proportions of NKT cells in spleen, liver and blood from B6 mice was performed on tail cuttings by PCR amplification of mice were significantly higher than from the other two strains the SSR D6mit135, which is tightly linked to the Nkrp1 (NK1.1) ( (Table 2 ). 1A). At the same age, four of 24 (17%) male heterozygous NK cell activity was studied in vivo using a model adapted mice and four of 17 (24%) male non-congenic mice had from that of Bix et al. (27) . CFSE-labeled (28), T-depleted developed diabetes (NS, 4-fold χ 2 table test; (Fig. 2) . NK cells in vivo, and in order to quantitate the difference in NK cell lytic activity between the NOD lines and to compare their levels of NK cell cytotoxicity with that of C57BL/6 mice, freshly isolated splenocytes from C57BL/6, NOD/Lt and presence of NK cell activity in vivo in NOD mice (Fig. 3) .
NOD.b-Nkrp1 b mice were tested in a 4-h 51 Cr-release assay. Furthermore, the numbers recovered differed between NOD/
The presence of NK cell activity in NOD mice was confirmed Lt and NOD.b-Nkrp1 b mice (9.0 Ϯ 3.3ϫ10 3 versus 2.4 Ϯ by the ability of splenocytes from both NOD/Lt and NOD.b-0.6ϫ10 4 respectively, n ϭ 5, P Ͻ 0.05, Mann-Whitney U-test), Nkrp1 b mice to lyse labeled target splenocyte blasts from suggesting that the Nkrp1 b congenic segment contained NOD.β 2 m -/-mice (Fig. 4) . This in vitro analysis did not genes which decreased NK cell-mediated cytotoxicity of identify any substantial difference in cytotoxic activity between class I MHC-deficient hemopoietic cells in this model. These splenocytes from the two NOD lines and both showed less findings were confirmed by the analysis of donor cells in the lytic activity (expressed as lytic units at an ET ratio of 20:1; spleens of irradiated recipients (data not shown).
LU 20 ) against NOD.β 2 m -/-blasts or B6.β 2 m -/-blasts than The validity of this in vivo measure of NK cell-mediated cytotoxicity was confirmed by comparing the efficacy of killing splenocytes from C57BL/6 mice ( Table 3 ). The lytic activities Lysis of wild-type targets was not detected (ND) and lytic activity was eliminated by prior in vivo treatment with PK136 (anti-NK1.1 Rx). (Table 3B) . line appeared to have less NK cell activity than the NOD/Lt line as determined by the in vivo model. As the donor bone marrow survival in either of the NOD lines was far greater than in B6 mice, the significance of this difference is unclear.
Comparison of NKT cells in NOD/Lt and NOD.b-Nkrp1 b mice
In order to determine if the Nkrp1 b congenic segment affected the number or function of NKT cells in the NOD.b-Nkrp1 b congenic mice, the numbers of, and IL-4 production by, thymic NKT cells in NOD/Lt and NOD.b-Nkrp1 b mice were compared. As the NK1.1 marker cannot be used to identify NKT cells in NOD/Lt mice, the surrogate phenotype αβTCR ϩ DN was used initially (21). No significant difference was found between the numbers of αβTCR ϩ DN cells in the thymuses of 8-week-old female NOD/Lt mice and those of NOD.bNkrp1 b mice (1.21 Ϯ 0.23ϫ10 5 versus 1.19 Ϯ 0.25ϫ10 5 ; n ϭ 5, NS, Mann-Whitney U-test), which in both cases was a third the numbers of αβTCR ϩ DN cells found in C57BL/6 mice (3.6 Ϯ 1.4ϫ10 5 ). difference in NKT cell numbers in spleen (Fig. 2) were correctly attributed or were actually due to the presence of contaminating lymphoid precursors of an Nkrp1 b mice were stimulated with plate-bound anti-CD3 mAb for 6 h, with Brefeldin A present for the last 4 h. The cells αβTCR ϩ CD62L ϩ CD4 ϩ immunoregulatory subset, as has been proposed by Herbelin et al. (29) . NK1.1 ϩ αβTCR ϩ DN NKT were then surface stained with anti-NK1.1 and anti-CD4, fixed, permeabilized, and stained for intracellular IL-4 and IFN-γ.
thymocytes were therefore compared to unmanipulated thymocytes for their ability to prevent diabetes after injection into While 25.9 Ϯ 1.9% of NK1.1 ϩ thymocytes from C57BL/6 mice contained IL-4, only 2.9 Ϯ 1.3% of NK1.1 ϩ thymocytes from female 3-week-old NOD/Lt mice. Whereas four of five (80%) mice receiving PBS and six of eight mice receiving unmanipul-NOD.b-Nkrp1 mice did so ( Fig. 6; P (25) . It was used as the segment donor instead of using B6 of NKT cells in the thymuses and lymph nodes of NOD mice was confirmed. In addition, anti-CD3 stimulation of NK1.1 ϩ directly, so that a pair of BALB-based control strains exist for comparisons of NK cell activity. In order to further aid such thymocytes revealed a further deficit in IL-4 production by NOD NKT thymocytes. The combined deficiencies in NKT comparisons, a NOD.c-H2 d congenic strain was simultaneously generated from the same cross.
cell number and IL-4 production result in a 20-fold reduction in IL-4 producing NKT cells in the thymuses of NOD.b-Nkrp1 The NKC lies adjacent to the genetic region containing the Idd19 diabetes susceptibility gene, which was identified in a mice compared to those of C57BL/6 mice. We have previously shown that a single i.v. injection of backcross with the PWK feral mouse strain (39) . In the NOD.b-Nkrp1 b congenic strain, this region (as defined by 1.0ϫ10 6 CD4 low/-CD8 -or DN thymocytes from female (BALB/ cϫNOD)F 1 or syngeneic donors protected intact NOD mice D6mit25) was still segregating at F 3 , with two-thirds of alleles tested being B6 type and one-third NOD. While it is not known from the spontaneous onset of clinical autoimmune diabetes (19, 22) . Further dissection of this thymocyte subset demonif B6 alleles of Idd19 can affect the incidence of diabetes in NOD mice, there was no evidence of such an effect in the strated that αβTCR ϩ DN cells were responsible for this activity, indicating that T cells were definitely involved and suggesting heterozygous congenic mice studied here.
Flow cytometric comparison of NOD.b-Nkrp1 b , BALB.B6-that NKT cells where most likely to be responsible (22) . Herbelin et al. (29) challenged this interpretation of our Cmv-1 r and C57BL/6 mice demonstrated for the first time that NOD mice have a relative deficiency of peripheral NK cells, data, suggesting that the results were due to the presence of contaminating lymphoid precursors of an which was associated with increased numbers of these cells in the bone marrow-suggesting that a defect in NK cell αβTCR ϩ CD62L ϩ CD4 ϩ immunoregulatory subset within the αβTCR ϩ DN population. Here, we have directly addressed export may be involved. As the NK-related complex contains a series of gene clusters which control the activity and this concern by comparing the protective activities of two subsets of DN thymocytes: one, which co-expressed both specificity of NK cells, the cytolytic activity of NK cells in NOD/ Lt and NOD.b-Nkrp1 b mice was compared in two assays.
αβTCR and NK1.1 markers; and the other, from which αβTCR ϩ NK1.1 ϩ NKT cells had been removed by FACS. While very In the first, a conventional in vitro 51 Cr-release assay, the splenocytes of both NOD lines were found to generate low numbers (2.5ϫ10 5 ) of thymocytes expressing the αβTCR and NK1.1 protected NOD mice from diabetes when injected comparable levels of cytotoxicity against NOD.β 2 m -/-splenic blasts, although these levels were substantially lower than into unmanipulated female NOD/Lt mice at 3 weeks of age, the remaining population contained no protective activity. This that provided by splenocytes from C57BL/6 mice against either NOD.β 2 m -/-or C57BL/6.β 2 m -/-splenic blasts. This experiment demonstrated conclusively that NKT cells, or a subset of NKT cells, are responsible for the protection from difference in NK cell activity between NOD mice and C57BL/6 mice could only partly be accounted for by the diabetes afforded by DN thymocytes. Carnaud et al. (40) recently reported evidence of crossreduced numbers of NK cells in the periphery of NOD mice. subsets. An interesting candidate for such a defect is the NKT cells (43, 44, 45) .
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